Furthermore, individuals aged 1849, 5069, and 70 showed increased risks of 101%, 78%, and 71%, respectively, for any psychiatric disease when using GLP-1 RAs compared to non-users
The consolidated MDL about GLP-1s and NAION has grown to about 86 lawsuits
In June of 2021, the FDA approved Wegovy and Ozempic, a drug that mimics a hormone called semaglutide (GLP-1) that helps regulate appetite and food intake, as a weight loss tool for chronic weight management
Resuming the normal dosing schedule and using simple reminders can help maintain consistency over time
Of course, there is a risk of addiction with these medications
Heres how GLP-1 compares: Ready to take the next step in your weight loss journey